Insulin regulation of gluconeogenesis

Abstract

The coordinated regulation between cellular glucose uptake and endogenous glucose production is indispensable for the maintenance of constant blood glucose concentrations. The liver contributes significantly to this process by altering the levels of hepatic glucose release, through controlling the processes of de novo glucose production (gluconeogenesis) and glycogen breakdown (glycogenolysis). Various nutritional and hormonal stimuli signal to alter hepatic gluconeogenic flux, and suppression of this metabolic pathway during the postprandial state can, to a significant extent, be attributed to insulin. Here, we review some of the molecular mechanisms through which insulin modulates hepatic gluconeogenesis, thus controlling glucose production by the liver to ultimately maintain normoglycemia. Various signaling pathways governed by insulin converge at the level of transcriptional regulation of the key hepatic gluconeogenic genes PCK1 and G6PC, highlighting this as one of the focal mechanisms through which gluconeogenesis is modulated. In individuals with compromised insulin signaling, such as insulin resistance in type 2 diabetes, insulin fails to suppress hepatic gluconeogenesis, even in the fed state; hence, an insight into these insulin-moderated pathways is critical for therapeutic purposes.

Atlas of Circadian Metabolism Reveals System-wide Coordination and Communication between Clocks

“…Muscle protein degradation and liver gluco- and glyceroneogenesis are under tight hormonal control, mainly by opposing actions of circulating glucocorticoids and insulin (Hatting et al, 2018; Schiaffino et al, 2013; Shimizu et al, 2015). The temporally-linked rise and fall of muscle and serum 3-methylhistidine on chow largely reflected 24-h oscillation of endogenous serum corticosterone (Figure 6D) and insulin (Jouffe et al, 2016).…”

A novel berberine‐metformin hybrid compound exerts therapeutic effects on obese type 2 diabetic rats

“…AMPK α and its downstream metabolic enzyme ACC have been identified as potential targets for the treatment of metabolic disorder, due to their inhibitory effects on glucose and lipid metabolism . Activation of AMPK/ACC pathway can enhance glucose uptake and glycolysis, while inhibit lipogenesis and cholesterol biosynthesis in the liver . Besides, G6Pase , FBPase and PEPCK genes are responsible for gluconeogenesis.…”

“…50 Activation of AMPK/ACC pathway can enhance glucose uptake and glycolysis, while inhibit lipogenesis and cholesterol biosynthesis in the liver. [51][52][53] Besides, G6Pase, FBPase and PEPCK genes are responsible for gluconeogenesis. It has been well established that the downregulation of G6Pase, FBPase and PEPCK genes can significantly inhibit gluconeogenesis, and subsequent reduce blood glucose levels.…”

Insulin as a model to teach three-dimensional structure of proteins

“…The hormone is popularly associated with diabetes and glucose blood control, though the insulin metabolic role is much more complex [30,31]. Insulin is a small protein containing 51 amino acid residues, with a molecular weight of approximately 6000 Da [31].…”